New roles for mean platelet volume measurement in the clinical practice?
P Noris, F Melazzini, CL Balduini - Platelets, 2016 - Taylor & Francis
Several hundreds of studies recently investigated mean platelet volume (MPV) as measured
by electronic cell counters in a wide variety of acquired diseases, and most of them found …
by electronic cell counters in a wide variety of acquired diseases, and most of them found …
Platelet populations and priming in hematological diseases
CC Baaten, H Ten Cate, PEJ van der Meijden… - Blood Reviews, 2017 - Elsevier
In healthy subjects and patients with hematological diseases, platelet populations can be
distinguished with different response spectra in hemostatic and vascular processes. These …
distinguished with different response spectra in hemostatic and vascular processes. These …
Platelet redox imbalance in hypercholesterolemia: a big problem for a small cell
The imbalance between reactive oxygen species (ROS) synthesis and their scavenging by
anti-oxidant defences is the common soil of many disorders, including …
anti-oxidant defences is the common soil of many disorders, including …
Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases
The vitamin D receptor (VDR) is a ligand-activated transcription factor that regulates gene
expression in many cell types, including immune cells. It requires binding of 1, 25 dihydroxy …
expression in many cell types, including immune cells. It requires binding of 1, 25 dihydroxy …
Pleiotropic effects of PCSK9: focus on thrombosis and haemostasis
M Puccini, U Landmesser, U Rauch - Metabolites, 2022 - mdpi.com
The proprotein convertase subtilisin/keying 9 (PCSK9) is a serine protease that has gained
importance in recent years as a drug target, mainly due to its effect on cholesterol …
importance in recent years as a drug target, mainly due to its effect on cholesterol …
Antiplatelet effects of PCSK9 inhibitors in primary hypercholesterolemia
Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors are a novel group of
hypolipidemic drugs that are recommended particularly for high-risk hypercholesterolemia …
hypolipidemic drugs that are recommended particularly for high-risk hypercholesterolemia …
The association between mean platelet volume and cardiovascular risk factors
N Sansanayudh, D Muntham, S Yamwong… - European Journal of …, 2016 - Elsevier
Background Mean platelet volume (MPV) correlates with platelet activation and has recently
emerged as a potential marker of cardiovascular diseases. Previous publications also …
emerged as a potential marker of cardiovascular diseases. Previous publications also …
Importance of coagulation factors as critical components of premature cardiovascular disease in familial hypercholesterolemia
U Ravnskov, M de Lorgeril, M Kendrick… - International Journal of …, 2022 - mdpi.com
For almost a century, familial hypercholesterolemia (FH) has been considered a serious
disease, causing atherosclerosis, cardiovascular disease, and ischemic stroke. Closely …
disease, causing atherosclerosis, cardiovascular disease, and ischemic stroke. Closely …
Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers
A Piccioni, E Niccolai, G Rozzi, G Spaziani, C Zanza… - Pathogens, 2023 - mdpi.com
Familial hypercholesterolemia is a common genetic disorder with a propensity towards early
onset of atherosclerotic cardiovascular disease (CVD). The main goal of therapy is to reduce …
onset of atherosclerotic cardiovascular disease (CVD). The main goal of therapy is to reduce …
Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia
U Ravnskov, M de Lorgeril, M Kendrick… - Medical Hypotheses, 2018 - Elsevier
High low-density-lipoprotein cholesterol (LDL-C) is routinely described as the main cause of
cardiovascular disease (CVD) in familial hypercholesterolemia (FH). However, numerous …
cardiovascular disease (CVD) in familial hypercholesterolemia (FH). However, numerous …